Federal authors are investigating the death of another child who is believed to have passed away after drinking formula made by Abbott Laboratories
Officials at the Food and Drug Administration (FDA) said an investigation was underway into the January death of a baby.
They said the FDA was notified of the death on June 10.
Abbott began recalling infant formula products and closed its Michigan factory in February after reports of serious bacterial infections in four infants.
Two of those died, and the FDA said it could not conclude whether Abbott’s formulation was the cause of illness or death. The company says there is no evidence to link its formula to illness or death.
Either way, the move exacerbated shortages among many manufacturers that began with pandemic supply chain problems, and led to criticism by the Biden administration that it was slow to act. active in recognizing the problem and responding to it.
Finally, the president enacted the Defense Production Act, which gives the government more control over industrial production during emergencies, to direct recipe ingredient suppliers to prioritize deliveries. for formula manufacturers.
He also founded Operation Fly Formula, directing the Department of Health and Human Services to import forums from abroad. At least six countries helped provide supplies.
In a statement, the agency said: “This most recent consumer complaint investigation is in its preliminary stages and the agency will provide updates as more information becomes known.”
It said agnency had previously reported reviewing claims related to the deaths of nine infants.
Only two cases were involved in the Abbott Nutrition Sturgis plant investigation, and despite extensive investigation, the evidence did not rule out or rule out a definite link between these infant deaths. and the product is manufactured at Abbott Nutrition’s Sturgis plant.
“The FDA is working day and night to ensure that parents and caregivers can easily find safe and nutritious formula products for any child in need.” FDA Commissioner Robert Califf said.
“I have personally spoken to infant formula manufacturers over the past few weeks and all of them have significantly ramped up their production efforts, resulting in more supplies that will be available on store shelves in the coming weeks. future.”
In a statement to The Independent, Abbott said: “The FDA notified Abbott of this case last week, but there was limited product and clinical information available to evaluate this case.” .
It added: “At this time, no conclusions can be drawn and there is no evidence to suggest a causal relationship between Abbott formulations and this reported case. If more information becomes available, we will investigate further according to our complaint handling process. “